Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 420

1.

Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.

Ma L, Zhou Z, Zhang D, Yang S, Wang J, Xue F, Yang Y, Yang R.

Thromb Haemost. 2012 May;107(5):937-50. doi: 10.1160/TH11-08-0596. Epub 2012 Mar 8.

PMID:
22398715
2.

Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.

Saeidi M, Masoud A, Shakiba Y, Hadjati J, Mohyeddin Bonab M, Nicknam MH, Latifpour M, Nikbin B.

Iran J Allergy Asthma Immunol. 2013 Mar;12(1):37-49. doi: 012.01/ijaai.3749.

3.

Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

Zhou C, Yang B, Tian Y, Jiao H, Zheng W, Wang J, Guan F.

Cell Immunol. 2011;272(1):33-8. doi: 10.1016/j.cellimm.2011.09.010. Epub 2011 Sep 29.

4.

Differentiation of umbilical cord mesenchymal stem cells into steroidogenic cells in comparison to bone marrow mesenchymal stem cells.

Wei X, Peng G, Zheng S, Wu X.

Cell Prolif. 2012 Apr;45(2):101-10. doi: 10.1111/j.1365-2184.2012.00809.x. Epub 2012 Feb 13.

PMID:
22324479
5.

Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis.

Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Guo J, Yu P, Li C, Liu X, Huang Z, Wang D, Li H, Gu Z, Liu B, Li Z.

Arthritis Res Ther. 2010;12(6):R210. doi: 10.1186/ar3187. Epub 2010 Nov 16.

6.

Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity.

Xu Y, Huang S, Ma K, Fu X, Han W, Sheng Z.

J Tissue Eng Regen Med. 2012 Aug;6(8):645-54. doi: 10.1002/term.468. Epub 2011 Sep 13.

PMID:
21916019
7.

Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells.

Liu S, Yuan M, Hou K, Zhang L, Zheng X, Zhao B, Sui X, Xu W, Lu S, Guo Q.

Cell Immunol. 2012 Jul-Aug;278(1-2):35-44. doi: 10.1016/j.cellimm.2012.06.010. Epub 2012 Jul 16.

PMID:
23121974
8.

Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.

Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H.

Biol Blood Marrow Transplant. 2007 Dec;13(12):1477-86.

9.

Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.

Chen MY, Lie PC, Li ZL, Wei X.

Exp Hematol. 2009 May;37(5):629-40. doi: 10.1016/j.exphem.2009.02.003.

PMID:
19375653
10.

Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura.

Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, Han ZC.

Haematologica. 2005 Jul;90(7):914-23.

11.

Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.

Manochantr S, U-pratya Y, Kheolamai P, Rojphisan S, Chayosumrit M, Tantrawatpan C, Supokawej A, Issaragrisil S.

Intern Med J. 2013 Apr;43(4):430-9. doi: 10.1111/imj.12044.

PMID:
23176558
12.

Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism.

Chen K, Wang D, Du WT, Han ZB, Ren H, Chi Y, Yang SG, Zhu D, Bayard F, Han ZC.

Clin Immunol. 2010 Jun;135(3):448-58. doi: 10.1016/j.clim.2010.01.015. Epub 2010 Mar 5.

PMID:
20207200
13.

Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells.

Wu LF, Wang NN, Liu YS, Wei X.

Tissue Eng Part A. 2009 Oct;15(10):2865-73. doi: 10.1089/ten.TEA.2008.0579.

PMID:
19257811
14.

Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury.

Fang TC, Pang CY, Chiu SC, Ding DC, Tsai RK.

PLoS One. 2012;7(9):e46504. doi: 10.1371/journal.pone.0046504. Epub 2012 Sep 27.

15.

Some viral microRNAs were up-regulated in megakaryocytes incubated with immune thrombocytopenia plasma.

Wang Y, Huang R, Song C, Hu H, Zhang M.

Eur J Haematol. 2013 Mar;90(3):220-7. doi: 10.1111/ejh.12063.

PMID:
23282244
16.

Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.

Liang L, Dong C, Chen X, Fang Z, Xu J, Liu M, Zhang X, Gu DS, Wang D, Du W, Zhu D, Han ZC.

Cell Transplant. 2011;20(9):1395-408. doi: 10.3727/096368910X557245. Epub 2011 Mar 9.

PMID:
21396175
17.

[Mechanism of cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura].

Wang L, Zhang F, Zhu YY, Li LZ, Ma DX, Hou M.

Zhonghua Yi Xue Za Zhi. 2005 Nov 16;85(43):3048-51. Chinese.

PMID:
16324405
18.

Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton's jelly.

Trivanović D, Kocić J, Mojsilović S, Krstić A, Ilić V, Djordjević IO, Santibanez JF, Jovcić G, Terzić M, Bugarski D.

Srp Arh Celok Lek. 2013 Mar-Apr;141(3-4):178-86.

19.

The defective bone marrow-derived mesenchymal stem cells in patients with chronic immune thrombocytopenia.

Zhang D, Li H, Ma L, Zhang X, Xue F, Zhou Z, Chi Y, Liu X, Huang Y, Yang Y, Yang R.

Autoimmunity. 2014 Dec;47(8):519-29. doi: 10.3109/08916934.2014.938320. Epub 2014 Jul 14.

PMID:
25019270
20.

Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.

Fong CY, Gauthaman K, Cheyyatraivendran S, Lin HD, Biswas A, Bongso A.

J Cell Biochem. 2012 Feb;113(2):658-68. doi: 10.1002/jcb.23395.

PMID:
21976004

Supplemental Content

Support Center